Equillium (EQ) Current Assets (2017 - 2026)
Equillium (EQ) reported Current Assets of $62.3 million for Q1 2026, up 284.03% year-over-year from $16.2 million in Q1 2025, and up 100.64% quarter-over-quarter from $31.0 million in Q4 2025.
Equillium (EQ) Current Assets (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Current Assets data on file, last reported at $62.3 million in Q1 2026.
- Current Assets for Q1 2026 came in at $62.3 million, up 284.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $62.3 million (up 284.03% YoY), and the FY2025 annual result was $31.0 million, up 24.26% from the prior year.
- Current Assets climbed to $62.3 million in Q1 2026 per EQ's latest filing, from $31.0 million in the prior quarter.
- Over five years, Current Assets peaked at $76.7 million in Q4 2022 and troughed at $12.0 million in Q2 2025.
- A 5-year average of $46.2 million and a median of $46.8 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets plunged 71.47% in 2025, then jumped 284.03% in 2026.
- A 5-year view of Current Assets shows it stood at $76.7 million in 2022, then plunged by 35.69% to $49.3 million in 2023, then slumped by 49.38% to $25.0 million in 2024, then climbed by 24.26% to $31.0 million in 2025, then surged by 100.64% to $62.3 million in 2026.
- Business Quant data shows EQ's Current Assets at $62.3 million in Q1 2026, $31.0 million in Q4 2025, and $33.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 62.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.28 Mn |
| Dec 31, 2025 | 31.04 Mn |
| Sep 30, 2025 | 33.58 Mn |
| Jun 30, 2025 | 11.95 Mn |
| Mar 31, 2025 | 16.22 Mn |
| Dec 31, 2024 | 24.98 Mn |
| Sep 30, 2024 | 33.65 Mn |
| Jun 30, 2024 | 41.89 Mn |
| Mar 31, 2024 | 42.48 Mn |
| Dec 31, 2023 | 49.35 Mn |
| Sep 30, 2023 | 53.91 Mn |
| Jun 30, 2023 | 57.36 Mn |
| Mar 31, 2023 | 70.22 Mn |
| Dec 31, 2022 | 76.74 Mn |
| Sep 30, 2022 | 46.78 Mn |
| Jun 30, 2022 | 60.48 Mn |
| Mar 31, 2022 | 72.09 Mn |
| Dec 31, 2021 | 83.37 Mn |
| Sep 30, 2021 | 92.17 Mn |
| Jun 30, 2021 | 99.57 Mn |